Aevice Health
AEvice Health | Better Control, Better Life.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | $7.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Aevice Health is a Singapore-based MedTech company specializing in the development of AI-powered wearable stethoscopes designed to monitor and analyze lung sounds for early detection of chronic respiratory disease exacerbations. The company's primary products, AeviceMD and AireSone Junior, empower patients to take control of their respiratory health by providing real-time, remote monitoring solutions. Aevice Health serves patients with chronic respiratory diseases, healthcare providers, and medical researchers, operating in the global healthcare market. The business model revolves around the sale of its innovative wearable devices and subscription-based services for continuous monitoring and data analysis. Revenue is generated through direct sales, partnerships with healthcare institutions, and licensing agreements.
Keywords: AI-powered, wearable stethoscopes, chronic respiratory disease, remote monitoring, lung sounds, early detection, healthcare, MedTech, data analysis, subscription services.